Unexpectedly, we also found that Rps27l, under the Trp53+/− background, acts as a tumor suppressor by maintaining the genomic integrity to prevent the loss of Trp53 heterozygosity and subsequent development of lymphoma. Here, RPS27L is linked to neoplasm.